Skip to main content
Top
Published in: Intensive Care Medicine 2/2007

01-02-2007 | Pediatric Brief Report

Persistently low plasma thioredoxin is associated with meningococcal septic shock in children

Authors: Matthew E. Callister, Anne Burke-Gaffney, Gregory J. Quinlan, Helen Betts, Simon Nadel, Timothy W. Evans

Published in: Intensive Care Medicine | Issue 2/2007

Login to get access

Abstract

Objective

To compare plasma levels of thioredoxin (Trx), TNF-α and IL-1β in children during the acute phase of meningococcal septic shock (MSS) and in convalescence.

Design and setting

Retrospective, observational study in the paediatric intensive care unit of a postgraduate teaching hospital.

Patients

Thirty-five children requiring intensive care for meningococcal sepsis; paired convalescent samples from 30 survivors (median interval between samples 62 days); 25 healthy control children.

Measurements and results

Plasma Trx levels were significantly lower in the children with MSS, both during the acute illness (5.5 ng/ml, IQR 1.4–11.4) and in convalescence (2.5 ng/ml, IQR 0.4–6.9) than controls (18.8 ng/ml, IQR 7.9–25.0). Levels of IL-1β and TNF-α were higher in patients with acute MSS (30.3 pg/ml, IQR 3.6–63.6, and 145.9 pg/ml, IQR 31.8–278.1 respectively) than controls (3.7 pg/ml, IQR 0–36.9, and 23.8 pg/ml, IQR 0–124.3, respectively). Levels fell in convalescence (3.7 pg/ml, IQR 0–25.5, 3.7 pg/ml, IQR 0–304.8, respectively). Plasma Trx was higher in non-survivors, albeit a small group (n = 5), than in survivors (n = 30). Trx, IL-1β, and TNF-α levels were not correlated with predicted mortality as assessed by the paediatric risk of mortality (PRISM) score.

Conclusions

Children with MSS exhibit persistently low plasma levels of Trx during acute illness and in convalescence.
Literature
1.
2.
go back to reference Festa M, Mumby S, Nadel S, Gutteridge JM, Quinlan GJ (2002) Antioxidant protection against iron in children with meningococcal sepsis. Crit Care Med 30:1623–1629PubMedCrossRef Festa M, Mumby S, Nadel S, Gutteridge JM, Quinlan GJ (2002) Antioxidant protection against iron in children with meningococcal sepsis. Crit Care Med 30:1623–1629PubMedCrossRef
3.
go back to reference Gromer S, Urig S, Becker K (2004) The thioredoxin system—from science to clinic. Med Res Rev 24:40–89PubMedCrossRef Gromer S, Urig S, Becker K (2004) The thioredoxin system—from science to clinic. Med Res Rev 24:40–89PubMedCrossRef
4.
go back to reference Burke-Gaffney A, Callister ME, Nakamura H (2005) Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26:398–404PubMedCrossRef Burke-Gaffney A, Callister ME, Nakamura H (2005) Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26:398–404PubMedCrossRef
5.
go back to reference Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef
6.
go back to reference Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603–611PubMedCrossRef Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603–611PubMedCrossRef
7.
go back to reference Holmgren A, Luthman M (1978) Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 17:4071–4077PubMedCrossRef Holmgren A, Luthman M (1978) Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 17:4071–4077PubMedCrossRef
8.
go back to reference Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, Evans TW (2006) Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 61:521–527PubMedCrossRef Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, Evans TW (2006) Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 61:521–527PubMedCrossRef
9.
go back to reference Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397–400PubMedCrossRef Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397–400PubMedCrossRef
10.
go back to reference Hazelzet JA, van der Voort E, Lindemans J, ter Heerdt PG, Neijens HJ (1994) Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intensive Care Med 20:371–374PubMedCrossRef Hazelzet JA, van der Voort E, Lindemans J, ter Heerdt PG, Neijens HJ (1994) Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intensive Care Med 20:371–374PubMedCrossRef
11.
go back to reference Ejima K, Koji T, Nanri H, Kashimura M, Ikeda M (1999) Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. Placenta 20:561–566PubMedCrossRef Ejima K, Koji T, Nanri H, Kashimura M, Ikeda M (1999) Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. Placenta 20:561–566PubMedCrossRef
12.
go back to reference Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F (1988) Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 263:15506–15:512PubMed Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F (1988) Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 263:15506–15:512PubMed
13.
go back to reference Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 367:156–161PubMedCrossRef Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 367:156–161PubMedCrossRef
14.
go back to reference Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556–560PubMedCrossRef Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556–560PubMedCrossRef
Metadata
Title
Persistently low plasma thioredoxin is associated with meningococcal septic shock in children
Authors
Matthew E. Callister
Anne Burke-Gaffney
Gregory J. Quinlan
Helen Betts
Simon Nadel
Timothy W. Evans
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 2/2007
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-006-0460-7

Other articles of this Issue 2/2007

Intensive Care Medicine 2/2007 Go to the issue

Announcements

Announcement